11月7日,登士柏国际(XRAY)股价在美国股市盘中出现剧烈震荡,一度大跌28.07%,引发投资者广泛关注。导致这一情况的主要原因是,公司在当天发布了两则重磅消息。
首先,登士柏国际下调了2024年全年每股收益预期,将其从之前1.96至2.02美元的区间,下调至1.82至1.86美元的水平。公司在财报中解释,此举是由于公司自愿暂停了旗下Byte矫正器和印模套件的销售、营销和发货。根据公司声明,上述产品线暂停是公司正在对与之相关的某些监管要求进行审查所致。
分析人士指出,下调年度利润预期加之暂停部分热销产品线,将对登士柏国际2024年的收入和利润造成不利影响,引发投资者对其前景产生担忧。尽管公司第三季度营收数据较为乐观,但似乎无法缓解外界疑虑。收盘时,登士柏国际股价报19.41美元,大跌21.93%,也创下了近24年来的新低。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.